LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Neutral With $7 Down From $10 Price Target 5/29/2025 10:43:14 AM
  • Intellia Therapeutics Presents Positive Two-Year Phase 1 Data On Nexiguran Ziclumeran At PNS 2025 Annual Meeting 5/18/2025 9:07:36 AM
  • Intellia Therapeutics' Nexiguran Ziclumeran Receives FDA RMAT Designation For ATTR-CM Treatment 3/26/2025 7:43:17 AM
  • Intellia Therapeutics Doses First Patient In The HAELO Phase 3 Study Of NTLA-2002 For Hereditary Angioedema 1/22/2025 7:38:21 AM
  • Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) FY25 Estimate To -3.95 From -5.44 1/10/2025 7:45:01 PM
  • Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q4 25 Estimate To -0.79 From -1.45 1/10/2025 7:44:50 PM
  • Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q3 25 Estimate To -0.86 From -1.44 1/10/2025 7:44:38 PM
  • Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) Q2 25 Estimate To -0.98 From -1.13 1/10/2025 7:44:22 PM
  • Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q1 25 Estimate To -1.33 From -1.42 1/10/2025 7:44:08 PM
  • Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) FY24 Estimate To -5.24 From -5.41 1/10/2025 7:43:31 PM
  • Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) Q4 24 Estimate To -1.25 From -1.42 1/10/2025 7:43:19 PM
  • Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Neutral With $10 Down From $14 Price Target 1/10/2025 7:42:50 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap